Penggunaan Antibakteri Golongan Carbapenem diatas Pasien dewasa Rawat Inap Sebuah Rumah Sakit Swasta di Surabaya


Kasus resistensi terhadap carbapenem merupakan deviasi satu masalah kesehatan global. Penggunaan yang noel bertanggung jawab secara luas, berulang, dan batin jangka waktu apa panjang merupakan faktor apa menentukan terjadinya fenomena tersebut. Hasil penelitian ini adalah memberikan gambaran penggunaan dan kesesuaian penggunaan carbapenem untuk beberapa diseases infeksi di ~ sebuah rumah sakit swasta di Surabaya. Penelitian ini merupakan penelitian penjelasan dengan manfaat data rekam medis pasien dewasa yang mendapatkan carbapenem selama titik Januari 2014–September 2014 such bahan penelitian. Penggunaan carbapenem dinyatakan batin defined daily dose (DDD). Tangani itu analisis kesesuaian jenis, dosis, dan berlanjut pemberian antibiotik dilakukan dengan benefit pedoman terapi Infectious condition Society the America (IDSA) terbaru such pustaka utama dan Drug details Handbook edisi 22 sebagai pustaka pendukung. Kesesuaian jenis antibiotik dibandingkan dengan gawangnya kultur juga dianalisis dalam penelitian ini. Sebanyak 255 data rekam medis pasien kematangan dianalisis batin penelitian ini. Kasar penggunaan carbapenem selama periode pengamatan sebesar 1462,25 DDD. Densitas penggunaan carbapenem dapat diklasifikasikan turun yaitu hampir 20% dari total pasien rawat inap per days mendapat carbapenem (19,39 DDD/100 bed-days). Sebagian terlalu tinggi penggunaan carbapenem thalamus secara IV bolus. Terdapat 72,95% dan 59,52% penggunaan carbapenem yang dinyatakan sesuai berdasarkan dianalisis dengan manfaat pedoman terapi dan tujuan kultur, secara berturut-turut. Mencapai mempertimbangkan mengajukan penggunaan tersebut, carbapenem perlu tangan kedua secara lebih bertanggung jawab. Penelitian terkait profil resistensi patogen terhadap golongan carbapenem harus dilakukan seperti bahan evaluasi pengambilan kebijakan terhubung dengan penggunaan antibakteri golongan tersebut.

Anda sedang menonton: Rumah sakit swasta di surabaya

Kata kunci: Carbapenem, DDD, defined day-to-day dose, drug utilization review

 

Carbapenem Utilization amongst Adults Inpatients in One exclusive Hospital in Surabaya

Carbapenem resistance is among the paling frightening diberkatilah anda problems globally. Maafkan saya determines the incident of carbapenem resistance phenomenon is the widely, repeated, irresponsible use of carbapenem end a long periode of time. This research study was aimed to provide an summary of the carbapenem utilization and its appropriateness compared with the guidelines. This study was a descriptive research study that analyzed medical record data of adult patient who digunakan carbapenem from januari to September 2014 in one exclusive hospital in Surabaya. The carbapenem utilization was identified in identified daily sheep (DDD). Identify the appropriateness of antibiotics’ type, dosage regimen, and also duration the treatment were conducted by lihat the newest Infectious an illness Society of America (IDSA) guidelines as the main reference and also Drug Infomation Handbook 22th version (2014) together the an additional reference. Moreover, the appropriateness of type of antibiotics tangan kedua for each patient was juga analyzed by comparing the yes, really dosage tangan kedua with the microbiology culture results. There menjadi 255 adult patient’s medical records digunakan in the current research. The berbisa amount the carbapenem utilization during the observation periode was 1462.25 DDD. The thickness of carbapenem utilization could be considered as low, i.e. Virtually 20% of berbisa inpatients every day being prescribed through carbapenem (19.39 DDD/100 bed-days). There menjadi 72.95% and 59.52% carbapenem utilization which dulu defined bugar based on the analysis lihat IDSA menginstruksikan and bacteria society results respectively. Considering the file of antibiotics utilization in this hospital, the antibiotics prescribing pattern could be boosted to a an ext responsible pattern. Lagi researches exploring the connection between pathogen resistance and also carbapenem intake need come be conducted in relation to the consideration in produksi local hospital regulation about the usage of antibiotics in the hospital settings.

Keywords: Carbapenem, DDD, identified daily dose, drug utilization review


Tortora G, Funke B, situation C. Microbiology: an introduction, 10th Edition. Mountain Francisco: Pearson Benjamin Cummings; 2010.

Gallagher J, MacDougall C. Antibiotics simplified, 2nd Edition. Unified States: David Cella; 2012.

Centers for disease Control and also Prevention (CDC). Antibiotic resistance risks in the United claims . Available from: http://www.cdc.gov/drugresistance/threat-report-2013/index.html

Apisarnthanarak A, Mundy L. Inappropriate usage of carbapenems in Thailand: A require for better education on de-escalation therapy. Clin infect Dis. 2008;47(6):858–9. Doi: 10.1086/591279.

Centers for disease Control and also Prevention (CDC). Around antimicrobial resistant . Available from: https://www.cdc.gov/drugresistance/about.html

Nicasio AM, Kuti JL, Nicolau DP. The present state that multidrug-resistant gram- negative bacilli in north America. Pharmacotherapy. 2008;28(2):235–49. Doi: 10.1592/phco.28.2.235.

Pakyz AL, Oinonen M, Polk RE. Partnership of carbapenem border in 22 university teaching hospitals come carbapenem use and carbapenem-resistant shuudomonas aeruginosa. Antimicrob Agents Chemother. 2009;53(5):1983–6.

Rhomberg PR, Jones RN. An overview trends for the Meropenem Yearly Susceptibility test Information collection Program: A 10-year suffer in the United claims (1999–2008). Diagn Microbiol infect Dis. 2009;65(4):414–26. Doi: 10.1016/j.diagmicrobio.2009.08.020.

European centre for an illness Prevention and also Control. Rates of carbapenem-resistant infections proceed to rise in Europe. 2013.

Hirsch EB, Tam VH. Dampak of multidrug- resistant Pseudomonas aeruginosa infection on patient outcomes. Skilled Rev Pharmacoecon Outcomes Res. 2011; 10(4):441–51. Doi: 10.1586/erp.10.49

Burns M, Dyer M, Bailit M. Reduce overuse and misuse: State strategies to enhance quality and pengeluaran of diberkatilah anda care . Accessible from: http://www.rwjf.org/en/library/research/2014/01/reducing-over use-and-misuse--state-strategies-to-impr ove-quality.html

World diberkatilah anda Organization. An interpretation and general consideration of characterized daily sheep (DDD) . Easily accessible from: https://www.whoc c.no/ddd/definition_and_general_considera/

Mir T, Dhobi GN, Koul AN, saleh T. Clinical file of classical demam of unknows asal (FUO). Casp J Intern Med. 2014;5(1):35–9.

Hersch E. Prolonged febrile illness and fever of unknown origin in adults. Am Fam Physician. 2014;90(2):91–6.

Cunha BA, Hage JE, Nouri Y. Recurrent demam of unknown origin (FUO): Aseptic meningitis, hepatosplenomegaly, pericarditis and also a double quotidian demam due to youth rheumatoid arthritis (JRA). Love Lung. 2012;41(2):177–80. Doi: 10.1016/j.hrtlng.2011.01.002.

Mouton JW, punting N, Vinks AA. Concentration-effect connection of ceftazidime explains why the time over the MIC is 40 percent because that a static effect in vivo. Antimicrob Agents Chemother. 2007;51(9):3449–51. Doi: 10.1128/AAC.01586-06

Burgess SV, Mabasa VH, Chow I, Ensom MHH. Evaluating outcomes of alternate dosing strategies for cefepime: A qualitative organized review. Ann Pharmacother. 2015;49(3):311­–22. Doi: 10.1177/1060028014564179

Roberts JA, Lipman J. Pharmacokinetic worries for antibiotics in the critically ok patient. Crit treatment Med. 2009; 37(3):840–51; doi: 10.1097/CCM.0b013e3181961bff.

Chant C, Leung A, Friedrich JO. Optimal dosing that antibiotics in critically ill patients by using continuous/extended infusions: A systematic tinjauannya and meta-analysis. Crit Care. 2013;17(6):R279. Doi: 10.1186/cc13134

Trissel L. Handbook the injectable drugs, 17th Ed. Joined States: American culture of Health-System Pharmacists; 2013.

Cook PP, Gooch M, Rizzo S. Reduction in fluoroquinolone usage following development of ertapenem into a hospital formulary is associated with improvement in susceptibility of Pseudomonas aeruginosa to group 2 carbapenems: A 10-year study. Antimicrob Agents Chemother. 2011;55(12):5597–601. Doi: 10.1128/AAC.00742-11

Eagye KJM, Nicolau DPPFF. Lack of association in between use the ertapenem and adjust in antipseudomonal carbapenem susceptibility rates in 25 hospitals. Infect regulate Hosp Epidemiol. 2010;31(5):485–90. Doi: 10.1086/652154.

McDougall DAJ, Morton AP, geoffrey Playford E. Combination of ertapenem and also antipseudomonal carbapenem usage and also carbapenem resistance in Pseudomonas aeruginosa among 12 hospitals in Queensland, Australia. J Antimicrob Chemother. 2013;68(2):457–60. Doi: 10.1093/jac/dks385

Livorsi D, Comer A, Matthias M, Perencevich E, Bair M. Determinants influencing antibiotic-prescribing decisions amongst inpatient physicians: A qualitative investigation. Infect regulate Hosp Epidemiol. 2015; 33(9):1065–72. Doi: 10.1017/ice.2015.136

Adorka M, Dikokole M, Kh M, Allen K. Healthcare providers’ attitudes and perceptions in infection diagnosis and antibiotic prescribing in public kesehatan institutions in Lesotho: A overcome sectional survey. African heal Sci. 2013;13(2):344–50. Doi: 10.4314/ahs.v13i2.21.

Schmitz RPH, Keller PM, Baier M, Hagel S, Pletz MW, Brunkhorst FM. High quality of blood culture testing-a inspection in intensive treatment units and also microbiological laboratories across four europe countries. Crit Care. 2013;17(5):R248. Doi: 10.1186/cc13074.

Polage CR, Bedu-addo G, Owusu-ofori A, Frimpong E, Lloyd W, Zurcher E, et al. Laboratory usage in Ghana: medical professional pereption and practice. Am J Trop Med Hyg. 2006;75(3):526–31.

Tsai D, Jamal JA, Davis JS, Lipman J, roberts JA. Interethnic differences in pharmacokinetics of antibacterials. Clin Pharmacokinet. 2015;54(3):243–60. Doi: 10.1007/s40262-014-0209-3.

Lihat lainnya: 7 Rekomendasi Hp Xiaomi Terbaru Harga Dan Spesifikasi Xiaomi Terbaru 2018


Digital object IdentifierDOI : https://doi.org/10.15416/ijcp.2017.6.4.267Article MetricsAbstract viewed : 0 times PDF (Bahasa Indonesia) perceived : 0 times Dimension quote Metrics

Refbacks

There are at this time no refbacks.

 Indonesian newspaper of Clinical Pharmacy is indexing by

*
*
 
*
 
*
 
*
 
*
*

*

IJCP by Universitas Padjadjaran is licensed dibawah a an innovative Commons Attribution-NonCommercial 4.0 worldwide License

 

*
<div class="statcounter"><a title="Web Analytics" href="https://statcounter.com/" target="_blank"><img class="statcounter" src="https://c.statcounter.com/11416645/0/fcc29140/0/" alt="Web Analytics"></a></div>